Atopic dermatitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 45: Line 45:
** Hyper-IgE syndrome  
** Hyper-IgE syndrome  
** Severe combined immunodeficiency (SCID)  
** Severe combined immunodeficiency (SCID)  
** Ataxia teleangiectasia
** Ataxia telangiectasia
* '''Metabolic Diseases'''
* '''Metabolic Diseases'''
** Phenylketonuria  
** Phenylketonuria  
Line 60: Line 60:
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
|Etiology
|Etiology
|Congenital
|Acquired
|Demography
|Demography
|History
|History
Line 67: Line 69:
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
|
|
|
|
|
|
Line 74: Line 78:
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
|-
|-
!
!
!
!
!
!
Line 82: Line 88:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
!
!
!
!
!
!
Line 98: Line 106:
!LFT
!LFT
|-
|-
!
!
!
!
!
!
Line 121: Line 131:
!
!
|-
|-
|Skin disorders
| rowspan="10" |Skin disorders
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Allergic contact dermatitis'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Allergic contact dermatitis'''
|
|
|
|
|
|
Line 144: Line 156:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Irritant contact dermatitis'''
|
|
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Irritant contact dermatitis'''
|
|
|
|
Line 167: Line 180:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic dermatitis'''
|
|
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic dermatitis'''
|
|
|
|
Line 190: Line 204:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Psoriasis'''
|
|
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Psoriasis'''
|
|
|
|
Line 213: Line 228:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Lichen simplex chronicus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|'''Ichthyosis vulgaris'''
|
|
|
|Lichen simplex chronicus
|
|
|
|
Line 236: Line 276:
|
|
|-
|-
|'''Nummular Dermatitis'''
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Netherton syndrome
|Netherton syndrome
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Dubowitz syndrome
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Erythrokeratodermia variabilis
|
|
|
|
|
|
Line 259: Line 372:
|
|
|-
|-
|Infection
| rowspan="6" |Infection
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Dermatophytes
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Dermatophytes
|
|
|
|
|
|
Line 282: Line 397:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Candida
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Herpes simplex
|
|
|
|Candida
|
|
|
|
Line 305: Line 445:
|
|
|-
|-
|Staphylococcus aureus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|'''Scabies'''
|'''Scabies'''
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|HIV
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
| rowspan="4" |Immunologic disorders
|Dermatitis herpetiformis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Pemphigus foliaceus
|
|
|
|
|
|
Line 328: Line 566:
|
|
|-
|-
|Graft-versus-host disease
|
|
|
|Herpes simplex
|
|
|
|
Line 351: Line 590:
|
|
|-
|-
|Dermatomyositis
|
|
|
|Staphylococcus aureus
|
|
|
|
Line 374: Line 614:
|
|
|-
|-
| rowspan="2" |Immune deficiency
| rowspan="5" |Immune deficiency
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Wiskott-Aldrich syndrome'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Wiskott-Aldrich syndrome'''
|
|
|
|
|
|
Line 397: Line 639:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Autosomal dominant hyperimmunoglobulin E syndrome'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Hyper-IgE syndrome'''
|
|
|
|
|
|
Line 419: Line 663:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Nutritional deficiencies
|DiGeorge syndrome
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Zinc deficiency'''
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Severe combined immunodeficiency (SCID)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Ataxia telangiectasia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
| rowspan="4" |'''Metabolic Diseases'''
|Phenylketonuria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Tyrosinemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Histidinemia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Multiple carboxylase deficiency
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Ichthyosis vulgaris'''
|
|
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| rowspan="2" |Malignancy
| rowspan="3" |Nutritional deficiencies
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Mycosis fungoides'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Zinc deficiency'''
|
|
|
|
|
|
Line 488: Line 857:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Histiocytosis X
|Pyridoxine deficiency
|
|
|
|
|
|
Line 510: Line 881:
|
|
|-
|-
|Niacin deficiency
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nummular Dermatitis'''
|
|
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| rowspan="2" |Malignancy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Mycosis fungoides'''
|
|
|
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Plaque Psoriasis'''
|
|
|
|
Line 556: Line 930:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Histiocytosis X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Medications
|Medications
|Infliximab
|
|
|
|
|
|

Revision as of 15:55, 11 October 2018

Atopic dermatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atopic dermatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atopic dermatitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atopic dermatitis differential diagnosis

CDC on Atopic dermatitis differential diagnosis

Atopic dermatitis differential diagnosis in the news

Blogs onAtopic dermatitis differential diagnosis

Directions to Hospitals Treating Atopic dermatitis

Risk calculators and risk factors forAtopic dermatitis differential diagnosis

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.


Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atopic dermatitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atopic dermatitis differential diagnosis

CDC on Atopic dermatitis differential diagnosis

Atopic dermatitis differential diagnosis in the news

Blogs on Atopic dermatitis differential diagnosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Atopic dermatitis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

Differentiating [Disease name] from other Diseases

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].

  • Chronic inflammatory skin diseases
    • Contact (allergic, irritant)
    • Seborrhoeic dermatitis
      • onset during the 1st days or weeks of life, absence of pruritus, and presence of greasy scaling on a yellow-red base
      • Involvement of the top of the scalp (cradle cap), axilla, and diaper area makes it more likely the patient has seborrheic dermatitis, vs excoriated dermatitis involving the extensor surfaces, face, and trunk favour AE.
    • Psoriasis
    • Lichen simplex chronicus
  • Infectious agents
    • Candida
    • Dermatophytes
    • Herpes simplex
    • Staphylococcus aureus
    • Sarcoptes scabiei
      • highly pruritic, erythematous papular lesions. In most cases, the typical burrows can be found on the flexor wrists, finger webs and genitalia. Similar symptoms in other family members
    • HIV-associated dermatitis
  • Immunologic disorders
    • Dermatitis herpetiformis
    • Pemphigus foliaceus
    • Graft-versus-host disease
    • Dermatomyositis
  • Malignant Diseases
    • Cutaneous T-cell lymphoma (mycosis fungoides, S´ezary syndrome)
    • Histiocytosis X (Letterer-Siwe disease)
  • Congenital disorders
    • Netherton’s syndrome
    • Dubowitz syndrome
    • Erythrokeratodermia variabilis
  • Immunodeficiencies
    • Wiskott-Aldrich syndrome (immunodeficiency with thrombocytopenia and eczema)
    • Thymic hypoplasia (DiGeorge syndrome)
    • Hyper-IgE syndrome
    • Severe combined immunodeficiency (SCID)
    • Ataxia telangiectasia
  • Metabolic Diseases
    • Phenylketonuria
    • Tyrosinemia
    • Histidinemia
    • Zinc deficiency
    • Pyridoxine (vitamin B6) and niacin deficiency
    • Multiple carboxylase deficiency
  • Nonallergic reaction to medication
    • Infliximab
Diseases Etiology Congenital Acquired Demography History Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Appearance Itching Fever BP Other CBC ESR/CRP BUN/Cr LFT
WBC Hb Plt
Skin disorders Allergic contact dermatitis
Irritant contact dermatitis
Seborrheic dermatitis
Psoriasis
Lichen simplex chronicus
Ichthyosis vulgaris
Nummular Dermatitis
Netherton syndrome
Dubowitz syndrome
Erythrokeratodermia variabilis
Infection Dermatophytes
Candida
Herpes simplex
Staphylococcus aureus
Scabies
HIV
Immunologic disorders Dermatitis herpetiformis
Pemphigus foliaceus
Graft-versus-host disease
Dermatomyositis
Immune deficiency Wiskott-Aldrich syndrome
Hyper-IgE syndrome
DiGeorge syndrome
Severe combined immunodeficiency (SCID)
Ataxia telangiectasia
Metabolic Diseases Phenylketonuria
Tyrosinemia
Histidinemia
Multiple carboxylase deficiency
Nutritional deficiencies Zinc deficiency
Pyridoxine deficiency
Niacin deficiency
Malignancy Mycosis fungoides
Histiocytosis X
Medications Infliximab

References


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Atopic_dermatitis_differential_diagnosis&oldid=1497460"